The BELIEVE Trial: Results of a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult beta-Thalassaemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

Porter, J.Shah, F.Drasar, E.Hill, Q. A.Telfer, P.Viprakasit, V.Taher, A.Georgiev, P.Kuo, K. H. M.Coates, T.Voskaridou, E.Liew, H. K.Pazgal-Kobrowski, I.Forni, G.Perrotta, S.Khelif, A.Lal, A.Kattamis, A.Vlachaki, E.Origa, R.Aydinok, Y.Bejaoui, M.Ho, P. J.Chew, L. P.Bee, P. C.Lim, S. M.Lu, M. -Y.Tantiworawit, A.Ganeva, P.Gercheva, L.Neufeld, E. J.Laadem, A.Shetty, J. K.Zou, J.Miteva, D.Zinger, T.Linde, P. G.Sherman, M.Hermine, O.Piga, A.Cappellini, M. D.2019-10-272019-10-2720190007-10481365-2141https://hdl.handle.net/11454/2918359th Annual Scientific Meeting of the British-Society-for-Hematology -- APR 01-03, 2019 -- Glasgow, SCOTLANDeninfo:eu-repo/semantics/closedAccessbeta-thalassaemiaclinical researchThe BELIEVE Trial: Results of a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult beta-Thalassaemia Patients Who Require Regular Red Blood Cell (RBC) TransfusionsConference Object185112113WOS:000462529200163Q1